Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- CPCB E-Waste EPR Registration Rejected? Brand Authorization Issues Explained
- Top SIMS 2.0 Registration Mistakes That Can Delay Your Imports
- How to Resolve IGST Refund Pending Issues After Shipping Bill Filing Quickly
- SIMS 2.0 Compliance Checklist for Steel Importers in India (2026)
- How to Calculate Plastic EPR Liability Correctly in 2026
- CPCB E-Waste Portal Errors: Common Problems and Solutions in 2026
- EPR Registration Rejection – Common Reasons & Solutions Guide 2026
- ICEGATE DSC Registration Error Solution
FeATURED ARTICLES
SARAL SIMS for Steel Imports in India – Complete Guide The Government of India has introduced SARAL SIMS (Simplified Steel…
Top Export Compliance Mistakes: DGFT Advance Authorization, EPCG & CPCB (2025 Guide) Exporting in India can feel like a legal…
Environmental Clearance CPCB: Quick Guide for Exporters If you’re an Indian exporter or manufacturer working under schemes like the Advanced…
DGFT e-BRC Rule 2025: Key Update for Advance Authorization & EPCG Holders The Directorate General of Foreign Trade (DGFT) has…
